New Zealand markets close in 5 hours 27 minutes

Context Therapeutics Inc. (CNTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2400+0.1400 (+6.67%)
At close: 04:00PM EST
2.2400 0.00 (0.00%)
After hours: 05:33PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 58.99M
Enterprise value 57.83M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA -7.24

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-58.82%
S&P500 52-week change 314.07%
52-week high 310.8700
52-week low 31.8300
50-day moving average 33.9293
200-day moving average 34.4277

Share statistics

Avg vol (3-month) 34.36M
Avg vol (10-day) 3675.53k
Shares outstanding 510.96M
Implied shares outstanding 6N/A
Float 86.06M
% held by insiders 124.11%
% held by institutions 140.81%
Shares short (30 Dec 2021) 4749.02k
Short ratio (30 Dec 2021) 40.09
Short % of float (30 Dec 2021) 47.49%
Short % of shares outstanding (30 Dec 2021) 46.83%
Shares short (prior month 29 Nov 2021) 4113.22k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-2.13M
Diluted EPS (ttm)-6.1070
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)419.15k
Total cash per share (mrq)0.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.10
Book value per share (mrq)-66.61

Cash flow statement

Operating cash flow (ttm)-4.01M
Levered free cash flow (ttm)N/A